Xylem Inc. $XYL Shares Bought by Mn Services Vermogensbeheer B.V.

Key Points

• Mn Services Vermogensbeheer B.V. increased its holdings in Xylem Inc. by 4.4%, owning 91,035 shares valued at approximately $11.8 million after acquiring additional shares in the second quarter.
• Xylem reported a strong earnings performance with $1.26 EPS for the latest quarter, exceeding the consensus estimate by $0.11, and yearly revenue showed a 6.1% increase.
• The company announced a quarterly dividend of $0.40 per share, set to be paid on September 25th, indicating an annualized dividend yield of 1.1%.

Mn Services Vermogensbeheer B.V. increased its position in Xylem Inc. (NYSE:XYL - Free Report) by 4.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 91,035 shares of the industrial products company's stock after buying an additional 3,800 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in Xylem were worth $11,776,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD lifted its stake in shares of Xylem by 689.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock valued at $443,074,000 after purchasing an additional 3,239,203 shares in the last quarter. Nuveen LLC acquired a new stake in shares of Xylem in the first quarter worth $99,726,000. OVERSEA CHINESE BANKING Corp Ltd raised its stake in shares of Xylem by 390.5% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock valued at $122,009,000 after acquiring an additional 813,100 shares during the period. Vaughan Nelson Investment Management L.P. acquired a new position in shares of Xylem during the 1st quarter valued at $89,828,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Xylem during the 4th quarter worth $83,139,000. Hedge funds and other institutional investors own 87.96% of the company's stock.

Xylem Stock Performance

Xylem stock traded down $0.00 during mid-day trading on Tuesday, reaching $143.54. The company's stock had a trading volume of 116,398 shares, compared to its average volume of 1,435,049. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.33. The business has a 50 day moving average price of $139.49 and a 200-day moving average price of $128.12. The firm has a market cap of $34.94 billion, a price-to-earnings ratio of 37.28, a PEG ratio of 2.47 and a beta of 1.09.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company had revenue of $2.30 billion for the quarter, compared to analysts' expectations of $2.20 billion. During the same period in the prior year, the company earned $1.09 earnings per share. The firm's revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Thursday, August 28th. Xylem's dividend payout ratio (DPR) is 41.56%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on XYL shares. TD Cowen upped their price target on Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a report on Tuesday, August 26th. UBS Group upped their price objective on shares of Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research report on Tuesday, August 5th. Citigroup reiterated a "buy" rating and issued a $152.00 price target (up previously from $137.00) on shares of Xylem in a research note on Monday, July 14th. Barclays started coverage on Xylem in a report on Friday. They set an "overweight" rating and a $165.00 price objective on the stock. Finally, Cowen reiterated a "hold" rating on shares of Xylem in a research note on Tuesday, August 26th. Seven research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $152.33.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares in the company, valued at approximately $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is currently owned by corporate insiders.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.